Pemphigus Vulgaris

Autoimmune Blistering Diseases Study

Effect of Topical Insulin on Healing Rate of Pemphigus Lesions

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

Low-level Laser Therapy on Oral Pemphigus Vulgaris Patients.

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)

Comparing DCP and DAP for Pemphigus Vulgaris

A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)

Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus

Dexamethasone Solution and Dexamethasone in Mucolox™

Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients

Role of Tzanck Smear in Determining Pemphigus Vulgaris Disease Activity

A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris

Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid

Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients

A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)

Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris

Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris